StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.52−0.07 (-4.40%)

Close on Nov 18, 2026Market cap $5.91MP/E –Yield –

Quantum Biopharma r&d expenses

Research and development expenses are spending on new products and technology.

Quantum Biopharma's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.58M, down 78.1% year over year. For fiscal 2025 it was $2.76M, down 54.6% from the year before. The highest annual figure on record is $7.83M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.76M-54.6%
FY2024Dec 31, 2024$6.08M+57.6%
FY2023Dec 31, 2023$3.86M-44.2%
FY2022Dec 31, 2022$6.91M+9.2%
FY2021Dec 31, 2021$6.33M-19.2%
FY2020Dec 31, 2020$7.83M–
FY2019Dec 31, 2019$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$387.43K-29.5%
Q1 FY2026Mar 31, 2026$626.09K-62.0%
Q4 FY2025Dec 31, 2025$70.40K-98.4%
Q3 FY2025Sep 30, 2025$495.22K-33.5%
Q2 FY2025Jun 30, 2025$549.20K-38.8%
Q1 FY2025Mar 31, 2025$1.65M+928.5%
Q4 FY2024Dec 31, 2024$4.28M+12876.6%
Q3 FY2024Sep 30, 2024$744.80K-53.8%
Q2 FY2024Jun 30, 2024$897.99K–
Q1 FY2024Mar 31, 2024$160.26K–
Q3 FY2023Sep 30, 2023$32.99K–
Q2 FY2023Jun 30, 2023$1.61M–

More Quantum Biopharma figures

See a number that looks wrong?